Skip to main content
. 2023 Mar 15;110(9):1080–1083. doi: 10.1093/bjs/znad066

Fig. 2.

Fig. 2

Heat map of individual ex vivo chemotherapy testing outcome for 78 patients

Each column represents one individual’s ex vivo sensitivity to the drugs indicated, with a highlighted frame around the drug(s) used for heated intraperitoneal chemotherapy (HIPEC). Patients having HIPEC with drug(s) scored sensitive or intermediate ex vivo were denoted the sensitive group when analysing survival data (Fig. 1).